https://www.ncbi.nlm.nih.gov/pubmed/32400117
Reverse swing-M, phase 1 study of repurposing mebendazole in recurrent high-grade glioma.
"Interpretation: The recommended phase 2 dose of mebendazole is 1600 mg TDS with temozolomide and temozolomide-radiation combination while the dose of 800 mg TDS needs to be used with single-agent CCNU."
TDS apparently means three times daily, so 1600 mg TDS = 4800 mg per day total.
No comments:
Post a Comment